Vimarsana
Biggest News Aggregation in the World

Page 3 - Practice Parameters News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Practice Parameters. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Practice Parameters Today - Breaking & Trending Today

ACAAI's two new yardsticks on managing eosinophilic esophagitis and cough published - Vimarsana News

ACAAI's two new yardsticks on managing eosinophilic esophagitis and cough published

Beginning in 2016, the American College of Allergy, Asthma and Immunology (ACAAI) began developing a series of yardsticks to help practitioners better understand the range of treatments available for allergic conditions.

Aquestive Therapeutics Announces Expert Allergy Scientific - Vimarsana News

Aquestive Therapeutics Announces Expert Allergy Scientific

WARREN, N.J., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to solve...

AAAAI Installs New President, Dr. David Khan, at 2022 Annual Meeting - Vimarsana News

AAAAI Installs New President, Dr. David Khan, at 2022 Annual Meeting

Phoenix, AZ (PRWEB) February 28, 2022 -- The American Academy of Allergy, Asthma & Immunology (AAAAI) is pleased to introduce its 2022-2023 President, David

Source: prweb.com
The Must-Read Acute Care Medicine Articles From 2021 - Vimarsana News

The Must-Read Acute Care Medicine Articles From 2021

Dr Amal Mattu discusses his top picks for the most important acute care literature of the past year. What are your picks?

Peanut Oral Immunotherapy Works in Toddlers: IMPACT Trial - Vimarsana News

Peanut Oral Immunotherapy Works in Toddlers: IMPACT Trial

After 2.5 years of peanut oral immunotherapy, 71% of toddlers could safely consume 17 peanuts, and more than 1 in 5 maintained this protection even after stopping treatment for 6 months.